Aclarion, Inc.
ACONNASDAQHealthcare● Active
$3.36
$-0.21(-5.88%)
Market Cap$1791918
P/E Ratio—
52W High$12.03
52W Low$2.34
Aclarion, Inc. (ACON) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACON · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 21, 2026EPS Actual
-$1.34
Est. -$1.55 · +13.6%
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 21, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
ACON reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$1.05 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 21, 2026 | -$1.55 | -$1.34 | +13.6% | $0.00B | $0.00B | +0.0% |
| — Q1 FY2026 | Feb 25, 2026 | -$3.60 | -$3.60 | +0.0% | $0.00B | $0.00B | +0.0% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$2.64 | -$2.93 | -11.0% | $0.00B | $0.00B | -0.3% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$2.26 | -$2.75 | -21.7% | $0.00B | $0.00B | -35.6% |
| ▲ Q2 FY2025 | May 15, 2025 | -$1447.20 | -$9.32 | +99.4% | $0.00B | $0.00B | -5.0% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$50.00 | -$1551.93 | -3003.9% | $0.00B | — | — |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$1621.62 | -$1351.35 | +16.7% | $0.00B | $0.00B | -4.0% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$1.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 21, 2026Beat
EPS Actual
-$1.34
EPS Est.
-$1.55
EPS Surpr.
+13.6%
Revenue
$0.00B
Q1 FY2026
Feb 25, 2026
EPS Actual
-$3.60
EPS Est.
-$3.60
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$2.93
EPS Est.
-$2.64
EPS Surpr.
-11.0%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$2.75
EPS Est.
-$2.26
EPS Surpr.
-21.7%
Revenue
$0.00B
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$9.32
EPS Est.
-$1447.20
EPS Surpr.
+99.4%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$1551.93
EPS Est.
-$50.00
EPS Surpr.
-3003.9%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$1351.35
EPS Est.
-$1621.62
EPS Surpr.
+16.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-1.36 | $-1.36 | $-1.36 | 1 |
| Q3 FY2027 | $-1.30 | $-1.30 | $-1.30 | 1 |
| Q2 FY2027 | $-1.30 | $-1.30 | $-1.30 | 1 |
| Q1 FY2027 | $-1.51 | $-1.51 | $-1.51 | 1 |
| Q4 FY2026 | $-1.09 | $-1.09 | $-1.09 | 1 |
| Q3 FY2026 | $-1.05 | $-1.05 | $-1.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 21, 2026 | +13.6% | $3.19 | $3.26 | +2.19% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +0.0% | $2.52 | $2.68 | +6.35% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -11.0% | $7.14 | $6.90 | -3.36% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -21.7% | $7.09 | $7.16 | +0.99% |
| ▲ Q2 FY2025 | May 15, 2025 | +99.4% | $7.16 | $6.90 | -3.63% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -3003.9% | $15.52 | $14.09 | -9.21% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +16.7% | $157.38 | $153.68 | -2.35% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -711136.8% | $209.66 | $188.14 | -10.26% |
Q2 FY2026+2.19%
Report Date
May 21, 2026
EPS Beat/Miss
+13.6%
Price Before
$3.19
Price After
$3.26
Q1 FY2026+6.35%
Report Date
Feb 25, 2026
EPS Beat/Miss
+0.0%
Price Before
$2.52
Price After
$2.68
Q4 FY2025-3.36%
Report Date
Nov 12, 2025
EPS Beat/Miss
-11.0%
Price Before
$7.14
Price After
$6.90
Q3 FY2025+0.99%
Report Date
Aug 14, 2025
EPS Beat/Miss
-21.7%
Price Before
$7.09
Price After
$7.16
Q2 FY2025-3.63%
Report Date
May 15, 2025
EPS Beat/Miss
+99.4%
Price Before
$7.16
Price After
$6.90
Q1 FY2025-9.21%
Report Date
Mar 27, 2025
EPS Beat/Miss
-3003.9%
Price Before
$15.52
Price After
$14.09
Q4 FY2024-2.35%
Report Date
Nov 14, 2024
EPS Beat/Miss
+16.7%
Price Before
$157.38
Price After
$153.68
Q3 FY2024-10.26%
Report Date
Aug 14, 2024
EPS Beat/Miss
-711136.8%
Price Before
$209.66
Price After
$188.14
Avg Beat Reaction+0.64%
Avg Miss Reaction-5.46%
Beat Rate4 / 8 quarters
Largest Move-10.26% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACON ends December
Aclarion, Inc. (ACON) most recently reported earnings on May 21, 2026 for Q2 FY2026, posting EPS of $-1.34 — beating the analyst consensus of $-1.55 by +13.6%. ACON has beaten EPS estimates for 2 consecutive quarters. The next ACON earnings date is expected around September 1, 2026.
Each quarter, investors track ACON earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACON revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACON's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACON earnings · 5 questionsAclarion, Inc.'s next earnings report is expected around September 1, 2026. ACON typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACON historically reports after market close (AMC).
ACON earnings datewhen is ACON earningsACON next earnings datewhen does ACON report earningsACON earnings calendar
▸ Source: FMP · Aclarion, Inc. SEC filings · US GAAP · Aclarion, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026